Moderna ETFs to Shine on Vaccine News as Outbreak Worsens
November 18, 2020 at 04:55 AM EST
The first company to begin human clinical trials of its coronavirus vaccine candidate in the United States — Moderna — has once again come up with encouraging study data relating to mRNA-1273.